{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:11:32Z","timestamp":1793398292184,"version":"4.5.0"},"reference-count":124,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIAMS","award":["AR079514"],"award-info":[{"award-number":["AR079514"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Millions of new cancer patients receive chemotherapy each year. In addition to killing cancer cells, chemotherapy is likely to damage rapidly proliferating healthy cells, including the hair follicle keratinocytes. Chemotherapy causes substantial thinning or loss of hair, termed chemotherapy-induced alopecia (CIA), in approximately 65% of patients. CIA is often ranked as one of the most distressing adverse effects of chemotherapy, but interventional options have been limited. To date, only scalp cooling has been cleared by the US Food and Drug Administration (FDA) to prevent CIA. However, several factors, including the high costs not always covered by insurance, preclude its broader use. Here we review the current options for CIA prevention and treatment and discuss new approaches being tested. CIA interventions include scalp cooling systems (both non-portable and portable) and topical agents to prevent hair loss, versus topical and oral minoxidil, photobiomodulation therapy (PBMT), and platelet-rich plasma (PRP) injections, among others, to stimulate hair regrowth after hair loss. Evidence-based studies are needed to develop and validate methods to prevent hair loss and\/or accelerate hair regrowth in cancer patients receiving chemotherapy, which could significantly improve cancer patients\u2019 quality of life and may help improve compliance and consequently the outcome of cancer treatment.<\/jats:p>","DOI":"10.3390\/curroncol30040275","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:31:21Z","timestamp":1679891481000},"page":"3609-3626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-7986","authenticated-orcid":false,"given":"Tongyu C.","family":"Wikramanayake","sequence":"first","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole I.","family":"Haberland","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Akhundlu","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Laboy Nieves","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Miteva","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"ref_1","unstructured":"World Cancer Research Fund International (2023, February 14). Worldwide Cancer Data. Available online: https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: A population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ad.2021.09.003","article-title":"Chemotherapy, Alopecia, and Scalp Cooling Systems","volume":"113","author":"Amarillo","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Shapiro","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/idoj.IDOJ_471_18","article-title":"A Descriptive Study to Analyze Chemotherapy-Induced Hair Loss and its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital","volume":"10","author":"Saraswat","year":"2019","journal-title":"Indian Dermatol. Online J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Trueb","year":"2009","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jocd.12308","article-title":"Chemotherapy-induced alopecia management: Clinical experience and practical advice","volume":"16","author":"Rossi","year":"2017","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2020074","DOI":"10.5826\/dpc.1003a74","article-title":"Prevention and Treatment of Chemotherapy-Induced Alopecia","volume":"10","author":"Rossi","year":"2020","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/ijd.15812","article-title":"Post-chemotherapy alopecia: What the dermatologist needs to know","volume":"60","author":"Santos","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia","volume":"155","author":"Chan","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/ecc.13395","article-title":"Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres","volume":"30","author":"Chan","year":"2021","journal-title":"Eur. J. Cancer Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamadermatol.2021.3676","article-title":"Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors","volume":"157","author":"Bhoyrul","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/bjd.20745","article-title":"Peroxisome proliferator-activated receptor-gamma signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial-mesenchymal transition","volume":"186","author":"Piccini","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e11031","DOI":"10.15252\/emmm.201911031","article-title":"CDK4\/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia","volume":"11","author":"Purba","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0022-202X.2004.23237.x","article-title":"Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia","volume":"123","author":"Hadshiew","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00520-009-0769-1","article-title":"Unanticipated toxicities from anticancer therapies: Survivors\u2019 perspectives","volume":"18","author":"Gandhi","year":"2010","journal-title":"Support. Care Cancer"},{"key":"ref_20","first-page":"567","article-title":"Ethical, legal, organizational and social issues related to the use of scalp cooling for the prevention of chemotherapy-induced alopecia: A systematic review","volume":"26","year":"2022","journal-title":"Health Expect."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Quesada, S., Guichard, A., and Fiteni, F. (2021). Cancer-Related Alopecia: From Etiologies to Global Management. Cancers, 13.","DOI":"10.3390\/cancers13215556"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103093","DOI":"10.1016\/j.critrevonc.2020.103093","article-title":"Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions","volume":"156","author":"Haque","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_23","unstructured":"Olver, I. (2018). Management of Alopecia Due to Cancer Therapies, Springer."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Olver, I. (2011). The MASCC Textbook of Cancer Supportive Care and Survivorship, Springer.","DOI":"10.1007\/978-1-4419-1225-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2022.03.031","article-title":"Low temperature mitigating the paclitaxel-induced damages in mouse cell and hair follicle model","volume":"603","author":"Chen","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","first-page":"231","article-title":"Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia","volume":"37","author":"Hillen","year":"1990","journal-title":"Neth. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1007\/s00520-021-06188-8","article-title":"The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: A systematic review and meta-analysis","volume":"29","author":"Wang","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-019-05169-0","article-title":"The effect of scalp cooling on CIA-related quality of life in breast cancer patients: A systematic review","volume":"175","author":"Marks","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5306\/wjco.v8.i4.329","article-title":"Platinum-induced neurotoxicity: A review of possible mechanisms","volume":"8","author":"Kanat","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","article-title":"Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia","volume":"18","author":"Komen","year":"2013","journal-title":"Oncologist"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1111\/jocd.14421","article-title":"Role of vitamin D in hair loss: A short review","volume":"20","author":"Saini","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/jocd.14844","article-title":"Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial","volume":"21","author":"Rashad","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00001813-199904000-00007","article-title":"A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia","volume":"10","author":"Hidalgo","year":"1999","journal-title":"Anticancer Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-020-06005-6","article-title":"A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia","volume":"186","author":"Lacouture","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/09298665113206660115","article-title":"An overview on keratinocyte growth factor: From the molecular properties to clinical applications","volume":"21","author":"Yen","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14764172.2018.1439965","article-title":"Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth\u2014Safety and efficacy evaluation in a first-in-man pilot clinical study","volume":"20","author":"Kapoor","year":"2018","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_37","first-page":"145","article-title":"Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu\/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia","volume":"147","author":"Danilenko","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2353\/ajpath.2007.061164","article-title":"Dissecting the impact of chemotherapy on the human hair follicle: A pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy","volume":"171","author":"Bodo","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.28961","article-title":"A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor","volume":"136","author":"Soref","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.7150\/jca.71263","article-title":"Low Intensity Ultrasound as an Antidote to Taxane\/Paclitaxel-induced Cytotoxicity","volume":"13","author":"Amaya","year":"2022","journal-title":"J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Amaya, C., Luo, S., Baigorri, J., Baucells, R., Smith, E.R., and Xu, X.X. (2021). Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08722-7"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0002-8703(80)90241-0","article-title":"Antihypertensive therapy: New pharmacological approaches","volume":"100","author":"Stokes","year":"1980","journal-title":"Am. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/dth.12390","article-title":"Multi-therapies in androgenetic alopecia: Review and clinical experiences","volume":"29","author":"Rossi","year":"2016","journal-title":"Dermatol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","article-title":"Minoxidil (Mx) as a prophylaxis of doxorubicin--induced alopecia","volume":"5","author":"Rodriguez","year":"1994","journal-title":"Ann. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","article-title":"Off-Label Use of Topical Minoxidil in Alopecia: A Review","volume":"20","author":"Stoehr","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A randomized trial of minoxidil in chemotherapy-induced alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jdcr.2022.01.035","article-title":"Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil","volume":"22","author":"Lyakhovitsky","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45366","DOI":"10.1038\/srep45366","article-title":"Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1015338","DOI":"10.3389\/fphar.2022.1015338","article-title":"Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4103\/ijo.IJO_2239_21","article-title":"Newer advances in medical management of glaucoma","volume":"70","author":"Mohan","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-3083.2004.01020.x","article-title":"Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost","volume":"18","author":"Herane","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0002-9394(03)01075-4","article-title":"Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost","volume":"137","author":"Hart","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/OPTH.S6480","article-title":"Bimatoprost in the treatment of eyelash hypotrichosis","volume":"4","author":"Law","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","article-title":"Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia","volume":"26","author":"Tosti","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00266-014-0293-7","article-title":"Bimatoprost for eyelash growth in Japanese subjects: Two multicenter controlled studies","volume":"38","author":"Harii","year":"2014","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bjd.13443","article-title":"Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: A randomized controlled trial","volume":"172","author":"Glaser","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0019-5154.152504","article-title":"Serendipity and its role in dermatology","volume":"60","author":"Coondoo","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Lonnfors","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_60","first-page":"541","article-title":"Female pattern alopecia: Current perspectives","volume":"5","author":"Levy","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/CCID.S184979","article-title":"Photobiomodulation for the management of alopecia: Mechanisms of action, patient selection and perspectives","volume":"12","author":"Hamblin","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Dompe, C., Moncrieff, L., Matys, J., Grzech-Lesniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., and Skiba, T.H.I. (2020). Photobiomodulation-Underlying Mechanism and Clinical Applications. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061724"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/443901a","article-title":"Cell biology: Power games","volume":"443","author":"Lane","year":"2006","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e14938","DOI":"10.1097\/MD.0000000000014938","article-title":"The role of photobiomodulation when associated with microneedling in female pattern hair loss: A randomized, double blind, parallel group, three arm, clinical study protocol","volume":"98","author":"Moita","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/lsm.22673","article-title":"A new path in defining light parameters for hair growth: Discovery and modulation of photoreceptors in human hair follicle","volume":"49","author":"Buscone","year":"2017","journal-title":"Lasers Surg. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/lsm.22173","article-title":"The growth of human scalp hair mediated by visible red light laser and LED sources in males","volume":"45","author":"Lanzafame","year":"2013","journal-title":"Lasers Surg. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/lsm.22277","article-title":"The growth of human scalp hair in females using visible red light laser and LED sources","volume":"46","author":"Lanzafame","year":"2014","journal-title":"Lasers Surg. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers Surg. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"40083","DOI":"10.1074\/jbc.M112.401604","article-title":"A photochromic histidine kinase rhodopsin (HKR1) that is bimodally switched by ultraviolet and blue light","volume":"287","author":"Luck","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10103-012-1139-7","article-title":"Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA)","volume":"28","author":"Wikramanayake","year":"2013","journal-title":"Lasers Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000477353","article-title":"A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification","volume":"4","author":"Alves","year":"2018","journal-title":"Ski. Appendage Disord."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mercuri, S.R., Paolino, G., Di Nicola, M.R., and Vollono, L. (2021). Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature. Medicina (Kaunas), 57.","DOI":"10.3390\/medicina57040311"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Verma, R., Kumar, S., Garg, P., and Verma, Y.K. (2022). Platelet-rich plasma: A comparative and economical therapy for wound healing and tissue regeneration. Cell Tissue Bank., 1\u201322.","DOI":"10.1007\/s10561-022-10039-z"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/term.3338","article-title":"Platelet-rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta-analysis","volume":"16","author":"Ebrahimi","year":"2022","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.oooo.2021.05.013","article-title":"Autologous platelet concentrates in oral surgery: Protocols, properties, and clinical applications","volume":"133","year":"2022","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","article-title":"Applications of the regenerative capacity of platelets in modern medicine","volume":"64","author":"Goszka","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mercuri, S.R., Di Nicola, M.R., Brianti, P., Bianchi, V.G., and Paolino, G. (2021). Pilot Study on the Use of the \u201cMonocyte-Rich\u201d Platelet-Rich Plasma in Combination with 1927 nm Fractional and 308 nm Excimer Lasers for the Treatment of Vitiligo. Medicina (Kaunas), 57.","DOI":"10.3390\/medicina57090904"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/09546634.2017.1303571","article-title":"Platelet rich plasma for treatment of non-scarring hair loss: Systematic review of literature","volume":"28","author":"Ayatollahi","year":"2017","journal-title":"J. Dermatolog. Treat"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/jdv.15207","article-title":"Chemotherapy-induced alopecia\u2014The urgent need for treatment options","volume":"33","author":"Sikora","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/DDDT.S356858","article-title":"Platelet Rich Plasma and Its Use in Hair Regrowth: A Review","volume":"16","author":"Paichitrojjana","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.reth.2022.10.005","article-title":"Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature","volume":"21","author":"Shimizu","year":"2022","journal-title":"Regen. Ther."},{"key":"ref_83","first-page":"24","article-title":"Platelet-rich plasma for the treatment of alopecia: A systematic review and meta-analysis","volume":"21","author":"Cruciani","year":"2021","journal-title":"Blood Transfus."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000503836","article-title":"The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia","volume":"6","author":"Stamatiou","year":"2020","journal-title":"Ski. Appendage Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.14340","article-title":"Spironolactone in dermatology: Uses in acne and beyond","volume":"45","author":"Searle","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_86","first-page":"e15321","article-title":"Spironolactone in dermatology","volume":"35","author":"Cazarin","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e151021197270","DOI":"10.2174\/1573403X17666211015145132","article-title":"Beneficial Extracardiac Effects of Cardiovascular Medications","volume":"18","author":"Butt","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"Burns","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijwd.2018.05.001","article-title":"Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review","volume":"4","author":"Fabbrocini","year":"2018","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2021.07.048","article-title":"Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review","volume":"86","author":"James","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ad.2020.03.001","article-title":"Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism","volume":"111","year":"2020","journal-title":"Actas Dermosifiliogr. (Engl. Ed.)"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5alpha-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"Rozner","year":"2019","journal-title":"Breast Cancer Res. Treat"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.12688\/f1000research.11887.1","article-title":"Spironolactone in cardiovascular disease: An expanding universe?","volume":"6","author":"Funder","year":"2017","journal-title":"F1000Research"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2021.5866","article-title":"Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-analysis","volume":"158","author":"Bommareddy","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: A retrospective, matched cohort study","volume":"83","author":"Mackenzie","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/bcp.14568","article-title":"Impact of spironolactone exposure on prostate cancer incidence amongst men with heart failure: A Pharmacoepidemiological study","volume":"87","author":"Hiebert","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/s41388-018-0654-9","article-title":"Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response","volume":"38","author":"Gold","year":"2019","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41391-020-0220-8","article-title":"Spironolactone use is associated with lower prostate cancer risk: A population-wide case-control study","volume":"23","author":"Beckmann","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2310\/7750.2014.13200","article-title":"Prevention of alopecia in medical and interventional chemotherapy patients","volume":"19","author":"Dmytriw","year":"2015","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Hawkshaw, N.J., Hardman, J.A., Haslam, I.S., Shahmalak, A., Gilhar, A., Lim, X., and Paus, R. (2018). Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2003705"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaad.2021.04.077","article-title":"Treatment of pediatric alopecia areata: A systematic review","volume":"86","author":"Barton","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0037-1615281","article-title":"Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center","volume":"34","author":"Heppt","year":"2018","journal-title":"Facial Plast. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJWH.S177308","article-title":"Frontal fibrosing alopecia: Efficacy of treatment modalities","volume":"11","author":"Gamret","year":"2019","journal-title":"Int. J. Womens Health"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/120347540100500409","article-title":"Tacrolimus in dermatology","volume":"5","author":"Guay","year":"2001","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s00520-021-06189-7","article-title":"Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia","volume":"29","author":"Yoneda","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsps.2017.12.013","article-title":"Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity\u2014Exploring the armoury of obscurity","volume":"26","author":"Singh","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lim, Y.C., Kim, H., Lim, S.M., and Kim, J.S. (2019). Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5323-z"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00595-010-4481-z","article-title":"The alpha-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: A pilot study","volume":"41","author":"Hagiwara","year":"2011","journal-title":"Surg. Today"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/cas.15639","article-title":"Efficacy of cooling therapy and alpha-lipoic acid derivative against chemotherapy-induced alopecia in an animal model","volume":"114","author":"Aiba","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2019.12.027","article-title":"Complementary and alternative medicine for alopecia areata: A systematic review","volume":"88","author":"Tkachenko","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000492035","article-title":"Complementary and Alternative Treatments for Alopecia: A Comprehensive Review","volume":"5","author":"Hosking","year":"2019","journal-title":"Ski. Appendage Disord"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-012-1253-1","article-title":"Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of L-cystine and vitamin B6","volume":"305","author":"Fiallo","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00520-019-04982-z","article-title":"Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: A pilot randomized double-blind controlled clinical trial (VOLUME RCT)","volume":"28","author":"Kang","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejon.2007.03.002","article-title":"Anticipating an altered appearance: Women undergoing chemotherapy treatment for breast cancer","volume":"11","author":"Frith","year":"2007","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"101840","DOI":"10.1016\/j.ejon.2020.101840","article-title":"The physical, psychological and social experiences of alopecia among women receiving chemotherapy: An integrative literature review","volume":"49","author":"Boland","year":"2020","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00002820-200601000-00006","article-title":"Postmenopausal women with breast cancer: Their experiences of the chemotherapy treatment period","volume":"29","author":"Browall","year":"2006","journal-title":"Cancer Nurs."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00002820-199408000-00006","article-title":"Social and cultural dimensions of hair loss in women treated for breast cancer","volume":"17","author":"Freedman","year":"1994","journal-title":"Cancer Nurs."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing patient perceptions of the side effects of cancer chemotherapy","volume":"95","author":"Carelle","year":"2002","journal-title":"Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors","volume":"80","author":"Shapiro","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00006534-198984040-00021","article-title":"Tattooing in reconstruction of the nipple and areola: A new method","volume":"84","author":"Masser","year":"1989","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/tbj.13427","article-title":"3D areola dermopigmentation (nipple-areola complex)","volume":"25","author":"Uhlmann","year":"2019","journal-title":"Breast J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_124","unstructured":"American Cancer Society (2022). Cancer Treatment & Survivorship Facts & Figures 2022\u20132024, American Cancer Society."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:03:06Z","timestamp":1760122986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":124,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["curroncol30040275"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30040275","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]}}}